A treatment where there are none. JR
Cerebello-spinal tDCS in ataxia
A randomized, double-blind, sham-controlled, crossover trial
https://n.neurology.org/content/91/12/e1090Conclusions A 2-week treatment with cerebello-spinal tDCS reduces symptoms in patients with ataxia and restores motor cortex inhibition exerted by cerebellar structures. Cerebello-spinal tDCS might represent a promising future therapeutic and rehabilitative approach in patients with neurodegenerative ataxia, still an orphan disorder of any pharmacologic intervention.
https://n.neurology.org/content/91/12/e1090
